SAM
RVMD icon

Smartleaf Asset Management’s Revolution Medicines RVMD Stock Holding History

Smartleaf Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9K Hold
150
– – ﹤0.01% 1815
2026
Q1 		$13.9K Sell
150
-63
-30% -$6.36K ﹤0.01% 2156
2025
Q4 		$17K Buy
213
+55
+35% +$3.61K ﹤0.01% 2120
2025
Q3 		$7.28K Buy
158
+35
+28% +$1.37K ﹤0.01% 2236
2025
Q2 		$4.54K Sell
123
-216
-64% -$8.3K ﹤0.01% 2086
2025
Q1 		$12.7K Sell
339
-149
-31% -$6.05K ﹤0.01% 1836
2024
Q4 		$21.1K Buy
488
+110
+29% +$5.55K ﹤0.01% 1611
2024
Q3 		$16.7K Buy
378
+151
+67% +$6.58K ﹤0.01% 1454
2024
Q2 		$8.75K Buy
+227
New +$8.48K ﹤0.01% 1479

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Smartleaf Asset Management's RVMD Position: Q2 2026 in Review

Smartleaf Asset Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 150 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Smartleaf Asset Management first reported a position in RVMD in Q2 2024 and has held it in 9 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Smartleaf Asset Management held 150 shares of Revolution Medicines worth $28.9K as of Q2 2026.
  • Smartleaf Asset Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1815 holding.
  • Smartleaf Asset Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 9 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.